Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:human
|
| gptkbp:awardReceived |
gptkb:Fellow_of_the_Academy_of_Medical_Sciences
gptkb:Fellow_of_the_Royal_Society |
| gptkbp:citizenship |
gptkb:United_Kingdom
|
| gptkbp:dateOfBirth |
1944
|
| gptkbp:educatedAt |
gptkb:University_College_London
gptkb:University_of_Cambridge |
| gptkbp:familyName |
gptkb:Pepys
|
| gptkbp:fieldOfWork |
gptkb:medicine
immunology |
| gptkbp:givenName |
gptkb:Mark
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sir Mark Walport Pepys
|
| gptkbp:knownFor |
studies on serum amyloid P component
|
| gptkbp:memberOf |
gptkb:Academy_of_Medical_Sciences
gptkb:Royal_Society |
| gptkbp:notableWork |
research on amyloidosis
|
| gptkbp:occupation |
gptkb:researchers
gptkb:immunologist |
| gptkbp:positionHeld |
Professor of Medicine, University College London
Director, UCL Centre for Amyloidosis and Acute Phase Proteins |
| gptkbp:title |
Sir
|
| gptkbp:bfsParent |
gptkb:Sir_Mark_Pepys
|
| gptkbp:bfsLayer |
6
|